5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000928320.14894.77 |
_version_ | 1797283716497670144 |
---|---|
author | M. Callaghan K.I. Ataga L. De Franceschi C. Minniti N. Balachandran D.-.C. Imbs T. Perretti J. Ramos A. Sostelly P. Bartolucci |
author_facet | M. Callaghan K.I. Ataga L. De Franceschi C. Minniti N. Balachandran D.-.C. Imbs T. Perretti J. Ramos A. Sostelly P. Bartolucci |
author_sort | M. Callaghan |
collection | DOAJ |
first_indexed | 2024-03-07T17:34:51Z |
format | Article |
id | doaj.art-361c984f428147c282c308015cd09ff4 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T17:34:51Z |
publishDate | 2023-04-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-361c984f428147c282c308015cd09ff42024-03-02T16:54:12ZengWileyHemaSphere2572-92412023-04-017S1262610.1097/01.HS9.0000928320.14894.77202304001-000485612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)M. CallaghanK.I. AtagaL. De FranceschiC. MinnitiN. BalachandranD.-.C. ImbsT. PerrettiJ. RamosA. SostellyP. Bartoluccihttp://journals.lww.com/10.1097/01.HS9.0000928320.14894.77 |
spellingShingle | M. Callaghan K.I. Ataga L. De Franceschi C. Minniti N. Balachandran D.-.C. Imbs T. Perretti J. Ramos A. Sostelly P. Bartolucci 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) HemaSphere |
title | 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_full | 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_fullStr | 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_full_unstemmed | 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_short | 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_sort | 5612539 trial in progress the randomized double blind placebo controlled phase 2a crosswalk c trial evaluating the efficacy of crovalimab as adjunct treatment in the prevention of vaso occlusive episodes voes in patients pts with sickle cell disease scd |
url | http://journals.lww.com/10.1097/01.HS9.0000928320.14894.77 |
work_keys_str_mv | AT mcallaghan 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT kiataga 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT ldefranceschi 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT cminniti 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT nbalachandran 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT dcimbs 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT tperretti 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT jramos 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT asostelly 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT pbartolucci 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd |